申请人:Eli Lilly and Company
公开号:US05747517A1
公开(公告)日:1998-05-05
This invention provides novel benzylidene rhodanines which are useful as agents in treating or preventing conditions associated with .beta.-amyloid peptide. This invention further provides methods of treating or preventing Alzheimer's Disease which comprises administering to a mammal in need thereof an effective amount of one or more of the benzylidene rhodanines of the present invention.
本发明提供了新型苄基亚硫酰罗丹明,其可用作治疗或预防与β-淀粉样肽相关的疾病的药物。本发明还提供了治疗或预防阿尔茨海默病的方法,该方法包括向需要的哺乳动物中施用本发明中的一种或多种苄基亚硫酰罗丹明的有效量。